Shahnazari M - Search Results

1

Inhibition of the progesterone nuclear receptor during the bone linear growth phase increases peak bone mass in female mice.

Yao W, Dai W, Shahnazari M, Pham A, Chen Z, Chen H, Guan M, Lane NE. Yao W, et al. Among authors: shahnazari m. PLoS One. 2010 Jul 1;5(7):e11410. doi: 10.1371/journal.pone.0011410. PLoS One. 2010. PMID: 20625385 Free PMC article.

2

Directing mesenchymal stem cells to bone to augment bone formation and increase bone mass.

Guan M, Yao W, Liu R, Lam KS, Nolta J, Jia J, Panganiban B, Meng L, Zhou P, Shahnazari M, Ritchie RO, Lane NE. Guan M, et al. Among authors: shahnazari m. Nat Med. 2012 Feb 5;18(3):456-62. doi: 10.1038/nm.2665. Nat Med. 2012. PMID: 22306732 Free PMC article.

3

Overexpression of secreted frizzled-related protein 1 inhibits bone formation and attenuates parathyroid hormone bone anabolic effects.

Yao W, Cheng Z, Shahnazari M, Dai W, Johnson ML, Lane NE. Yao W, et al. Among authors: shahnazari m. J Bone Miner Res. 2010 Feb;25(2):190-9. doi: 10.1359/jbmr.090719. J Bone Miner Res. 2010. PMID: 19594295 Free PMC article.

4

Differential maintenance of cortical and cancellous bone strength following discontinuation of bone-active agents.

Shahnazari M, Yao W, Wang B, Panganiban B, Ritchie RO, Hagar Y, Lane NE. Shahnazari M, et al. J Bone Miner Res. 2011 Mar;26(3):569-81. doi: 10.1002/jbmr.249. J Bone Miner Res. 2011. PMID: 20839286 Free PMC article.

5

Glucocorticoid dose determines osteocyte cell fate.

Jia J, Yao W, Guan M, Dai W, Shahnazari M, Kar R, Bonewald L, Jiang JX, Lane NE. Jia J, et al. Among authors: shahnazari m. FASEB J. 2011 Oct;25(10):3366-76. doi: 10.1096/fj.11-182519. Epub 2011 Jun 24. FASEB J. 2011. PMID: 21705669 Free PMC article.

6

Prolonged alendronate treatment prevents the decline in serum TGF-β1 levels and reduces cortical bone strength in long-term estrogen deficiency rat model.

Jia J, Yao W, Amugongo S, Shahnazari M, Dai W, Lay YA, Olvera D, Zimmermann EA, Ritchie RO, Li CS, Alliston T, Lane NE. Jia J, et al. Among authors: shahnazari m. Bone. 2013 Jan;52(1):424-32. doi: 10.1016/j.bone.2012.10.017. Epub 2012 Oct 23. Bone. 2013. PMID: 23088940 Free PMC article.

7

Targeting the Wnt signaling pathway to augment bone formation.

Shahnazari M, Yao W, Corr M, Lane NE. Shahnazari M, et al. Curr Osteoporos Rep. 2008 Dec;6(4):142-8. doi: 10.1007/s11914-008-0025-5. Curr Osteoporos Rep. 2008. PMID: 19032924 Free PMC article.

8

Higher doses of bisphosphonates further improve bone mass, architecture, and strength but not the tissue material properties in aged rats.

Shahnazari M, Yao W, Dai W, Wang B, Ionova-Martin SS, Ritchie RO, Heeren D, Burghardt AJ, Nicolella DP, Kimiecik MG, Lane NE. Shahnazari M, et al. Bone. 2010 May;46(5):1267-74. doi: 10.1016/j.bone.2009.11.019. Epub 2009 Nov 26. Bone. 2010. PMID: 19931661 Free PMC article.

9

Osteoporosis in men: findings from the Osteoporotic Fractures in Men Study (MrOS).

Cawthon PM, Shahnazari M, Orwoll ES, Lane NE. Cawthon PM, et al. Among authors: shahnazari m. Ther Adv Musculoskelet Dis. 2016 Feb;8(1):15-27. doi: 10.1177/1759720X15621227. Ther Adv Musculoskelet Dis. 2016. PMID: 26834847 Free PMC article. Review.

10

Targeted deletion of Sost distal enhancer increases bone formation and bone mass.

Collette NM, Genetos DC, Economides AN, Xie L, Shahnazari M, Yao W, Lane NE, Harland RM, Loots GG. Collette NM, et al. Among authors: shahnazari m. Proc Natl Acad Sci U S A. 2012 Aug 28;109(35):14092-7. doi: 10.1073/pnas.1207188109. Epub 2012 Aug 10. Proc Natl Acad Sci U S A. 2012. PMID: 22886088 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35 results

Search Page

Filters